Economic value dossiers for influenza vaccines in a) an unprimed paediatric population and b) a primed school age population (intranasal delivery) including literature review, gap analysis and recommendations
Communications package for an influenza vaccine
Communication of the economics of an influenza vaccine
Two manuscripts on an influenza vaccine for patients at risk and patients over 65 years old in France
Review of influenza vaccine uptake data
Updating an economic model of influenza vaccination (phase 1) – update of a model in patients aged over 65 years in France and the UK
Economic evaluation of a workplace influenza vaccination in Russia
Cost-effectiveness analysis of an influenza vaccine
Adaptation of a cost effectiveness model for an influenza vaccine for Germany, Austria and Mexico
Conference poster on the cost effectiveness of adjuvant influenza vaccination in France
Adaptation of an influenza vaccine model to Belgium
Regulatory support for the validation of a questionnaire for influenza vaccination
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.